Introduction
The stem cells of the blood have set the paradigm for all stem cell systems, i.e., a rare cell being on top of the hierarchy of differentiating daughter cells from different lineages and having the ability to self-renew (1) . Hematopoiesis, the process of blood formation, has been the experimental system of choice for the phenotypic, molecular and functional definition of stem cells. An overwhelming number of studies have dealt with signaling pathways governing HSC fate (either self-renewal, proliferation, differentiation, apoptosis, or quiescence), including the evolutionary conserved Wnt pathway [for instance reviewed in (2, 3) ]. Other important pathways such as Notch, hedgehog, SMAD, FGF and receptor tyrosine kinase also regulate HSC biology [see for instance (4) ]. However, in contrast to other stem cell systems, where Wnt signaling is the major driving force for self-renewal (5), the role of Wnt signaling in blood stem cells has been somewhat controversial [recently reviewed in (6) ]. This probably has to do with the relatively low levels of Wnt signaling required for normal HSC function compared to for instance intestinal stem cells and with the fact that much higher levels of Wnt signaling invariably lead to stem cell exhaustion in blood (7, 8) .
Wnt signaling
The Wnt signaling cascade is often discerned into the canonical or Wnt/β-catenin pathway and the noncanonical pathways that do not use β-catenin as protein to transfer the cytoplasmic Wnt signal to a nuclear response (9) (10) (11) (12) (13) . In the canonical pathway, cytoplasmic levels of β-catenin are kept very low through the action of a protein complex (the so-called destruction complex) that actively targets β-catenin for degradation. Activation of the canonical pathway by binding of a Wnt protein to a Frizzled receptor, leads to inactivation of the destruction complex allowing built-up of the dephosphorylated form of β-catenin and its migration to the nucleus. In the nucleus, β-catenin binds to members of the TCF/LEF transcription factor family, thereby converting them from transcriptional repressors into transcriptional activators. It should be noted that TCF/LEF factors also function as transcriptional repressors, in part through binding of Groucho-TLE corepressors (14) . Also in hematopoietic cells the repressor function of these factors is important, as for instance shown in the thymus where loss of Tcf1 predisposes to the development of leukemia (15, 16) .
Non-canonical Wnt signaling uses Wnt/Fz ligand/ receptors yet does not signal via β-catenin, but uses JNK kinases, intracellular free calcium or entirely other receptors for instance Ryk or Ror (13) . Biologically, they can inhibit the canonical pathway or are involved in cell polarity or cell motility. Importantly, non-canonical Wnt signaling has been proposed to regulate quiescence of HSCs (11, 17) .
Epigenetics and Sirtuins
Besides through various signaling pathways, HSC are also subject to epigenetic control. Epigenetic changes modify the activation of genes, but not their DNA sequence. Common epigenetic changes are methylation of DNA (e.g., cytosine methylation in so-called CpG islands) or modifications of histone proteins (e.g., lysine acetylation, lysine and arginine methylation, serine and threonine phosphorylation, and lysine ubiquitination and sumoylation) (18) . Especially acetylation of histone proteins has been highly studied as it directly affects the activity of the nucleosome-associated genes. Histone acetyltransferase enzymes (HATs) and histone deacetylases (HDACs) regulate the acetylation status of histone proteins, in particular H3 and H4. The Sirtuin family of proteins also have deacetylase activity and are thought to play key roles in metabolism, immunity, ageing and apoptosis [reviewed in e.g., (19) ]. In mammals there are seven Sirtuins (SIRT1-7). Interestingly, the HDAC activity of sirtuins is dependent on NAD(P) and therefore directly linked to the energy metabolism of cells. Indeed the function of some Sirtuins (Sirt3, Sirt7) is intimately linked to proper mitochondrial function. Sirt3 (20) and Sirt7 deficiency (21) both affect HSC selfrenewal by influencing the function of mitochondria and the unfolded protein response, thereby mimicking stem cell ageing. Sirt6 deficient mice also have an aging phenotype, but transplantation of Sirt6 −/− bone marrow cells showed surprisingly little effect (22) . This is in sharp contrast to an elaborate recent study in which Sirt6 was conditionally deleted in the hematopoietic system (23).
Targeted mutation of Sit6 in HSC
The function of Sirt6 in HSC was studied by Wang et al. in detail using a floxed version rather than straight knockout of the gene (23) . To their credit, these investigators not only used the sometimes problematic Mx-Cre system (which requires poly I-C injections thereby mimicking an inflammatory response which effects many cells, such as intestinal epithelium in addition to blood cells) but also ERT2-Cre and Vav-cre. They observed an increase in phenotypic HSCs, yet these were hyper activated, residing much more in G1/S than wild type HSC, showed increased proliferative capacity leading to eventual HSC exhaustion. (25) . CBP or its homolog p300 act as transcriptional co-activators that are recruited by the TCF-catenin complex. ICG-001 inhibits CBP but not p300, so not all target genes are expected to be fully affected by this drug. Of interest, the Wnt target genes affected were similar to those recently found in gene expression profiling studies using floxed Apc alleles in HSCs (26) . APC is a negative regulator of the pathway and when deleted in HSCs leads to upregulation of Wnt target genes such as Axin2, Tcf7 and CyclinD2 and subsequently to stem cell exhaustion. Famili et al. showed that this stem cell exhaustion is mainly caused by enhanced differentiation into both granulocytic and B lymphoid lineages (26) . Taken together, Sirt6 functions to prevent hyper activation of Wnt signalling under quiescent conditions, and is less active under inflammatory and stressed situations when canonical Wnt signals activate HSCs to produce more blood cells (see Figure 1 ). Sirtuins together with other factors ensure that under the specific conditions, the "juts-right" levels of Wnt signalling for that condition are activated.
Non-canonical Wnt signalling
While the work on Sirt6 discussed above indicates that it functions to dampen Wnt signaling to prevent hyper proliferation of HSCs, other related work has shown that non-canonical Wnt signaling is required to maintain HSC quiescence. Frizzled8, together with Flamingo, is a noncanonical Wnt receptor that responds to non-canonical Wnts such as Wnt5a. Under stressed conditions, canonical Wnt signaling is enhanced to activate HSCs and induce self-renewal and differentiation (17) . Indeed, noncanonical Wnt5a signaling is increased in short-term HSC repopulation by maintaining HSCs in a quiescent G(0) state (27) . It would be interesting to explore if canonical and non-canonical Wnt signalling are differentially affected in Sirt6 deficient HSCs. Such differential effects of canonical (exemplified by Wnt3a) and non-canonical (Wnt5a mediated) signalling was recently shown in HSCs, where Wnt3a led to higher lymphoid output whereas Wnt5a led to higher myeloid output in vivo (28) .
Future directions
The role of epigenetic changes with regards to Wnt signalling has been highlighted in haematological malignancies where methylation of key Wnt genes has been demonstrated (29) (30) (31) (32) . It would be of great interest to see if Sirtuins play a role in human haematological malignancies. Also, given the changes in Sirt6 expression in the thymus (Staal, unpublished) and the importance of Wnt signalling for thymic development (33, 34) , a role for Sirt6 in T cell development can be predicted. Such a role can be directly addressed using Lck-Cre or CD4-cre mice crossed to the floxed mice used by Wang et al. (23) . Wnt signalling is explored as a way to expand HSC ex vivo. However this is not an easy task by using Wnt alone, hence other signals such as PI3K/Akt signalling (35) , as well as expression of Bcl2 (36) can provide such signals. Inhibition of the mTOR pathway using rapamycin, together with pharmacological activation of the Wnt pathway, has also been proposed (37) . Based on the new insights discussed here, it would be worthwhile to consider controlled epigenetic changes in to such expansion protocols as well. 
